Weizmann’s study sheds new light on a promising antidepressant
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
Tislelizumab is now approved in nine indications in China
Successfully removed peanut from the child’s left lung through bronchoscopy
NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Avacc 3 has significant advantages over existing whooping cough vaccines
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Dupixent peak sales ambition raised to more than €13 billion
Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
Subscribe To Our Newsletter & Stay Updated